The clinical features, laboratory findings, treatment and follow-up results of patients with morphea

Parlak N., AKAY B. N., Sanli H. E., Akyol A.

TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, vol.47, no.4, pp.209-213, 2013 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 4
  • Publication Date: 2013
  • Doi Number: 10.4274/turkderm.05657
  • Journal Name: TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.209-213
  • Keywords: Autoantibodies, colchicine, localized scleroderma, morphea, LOCALIZED SCLERODERMA, METHOTREXATE, CHILDREN, EPIDEMIOLOGY, UPDATE, SERIES
  • Ankara University Affiliated: Yes

Abstract

Background and Design: Morphea, also known as localized scleroderma, is a rare skin disease of unknown pathogenesis, characterized by fibrosis of the skin and subcutaneous tissue. In this study, we aimed to evaluate the demographic features, clinical characteristics, laboratory. findings, and response to treatment in patients diagnosed with morphea.